Get startedLog in
    Picture of Centessa Pharmaceuticals logo

    CNTA — Centessa Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Centessa Pharmaceuticals Demonstrates Proof-Of-Mechanism From First Three PiMZ Subjects Dosed In Part B Of Phase 1 Study

    Picture of Centessa Pharmaceuticals logoCentessa Pharmaceuticals
    01/11/2021 11:39
    Nov 1 (Reuters) - Centessa Pharmaceuticals PLC  260y.F :
    * CENTESSA PHARMACEUTICALS DEMONSTRATES PROOF-OF-MECHANISM
FROM
FIRST THREE PIMZ SUBJECTS DOSED IN PART B OF PHASE 1 STUDY
EVALUATING ZF874

Source text for Eikon:  ID:nGNXyMnJN 
Further company coverage:  260y.F 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Centessa Pharmaceuticals

    See all news